Phospho-ABL1 (Y204) Antibody

What is Phospho-ABL1 (Y204) Antibody and what does it specifically detect?

Phospho-ABL1 (Y204) Antibody is a specialized immunological reagent designed to recognize the ABL1 protein only when phosphorylated at tyrosine 204. This site-specific phosphorylation detection allows researchers to monitor the activation status of ABL1 tyrosine kinase in various cellular contexts. The antibody is typically generated using synthetic phosphopeptides corresponding to residues surrounding Y204 of human ABL1 as immunogens . In contrast to general ABL1 antibodies that detect the protein regardless of phosphorylation state, phospho-specific antibodies enable precise monitoring of post-translational modifications that regulate ABL1 signaling activity.

What experimental applications can Phospho-ABL1 (Y204) Antibody support?

Phospho-ABL1 (Y204) Antibody can be utilized across multiple experimental platforms:

• Western Blot (WB): Allows detection of phosphorylated ABL1 protein in cell lysates, typically recommended at dilutions of 1:500-1:2000

• Immunohistochemistry (IHC): Enables visualization of phosphorylated ABL1 in tissue sections, with optimal dilutions of 1:50-1:300

• Enzyme-Linked Immunosorbent Assay (ELISA): Provides quantitative measurement of phosphorylated ABL1, typically at dilutions around 1:5000

For validation purposes, multiple experimental approaches should be employed to confirm specificity and reproducibility of results.

What species reactivity should researchers expect with Phospho-ABL1 (Y204) Antibody?

Commercially available Phospho-ABL1 (Y204) antibodies typically demonstrate cross-reactivity across several mammalian species due to the high conservation of the ABL1 sequence around Y204. The antibody has been validated to react with:

• Human ABL1

• Mouse ABL1

• Rat ABL1

• Monkey ABL1

When working with non-validated species, preliminary testing is strongly recommended, as sequence variations around the phosphorylation site may affect antibody recognition and binding affinity.

What are the optimal storage conditions for maintaining Phospho-ABL1 (Y204) Antibody activity?

To maintain antibody functionality and prevent degradation:

• Long-term storage: Store at -20°C for preservation up to one year

• Short-term/frequent use: Store at 4°C for up to one month

• Avoid repeated freeze-thaw cycles that can denature proteins and reduce antibody activity

• Store in aliquots to minimize freeze-thaw events

• Typical storage buffer composition includes PBS with glycerol (50%), BSA (0.5%), and sodium azide (0.02%) as preservative

Following these storage guidelines ensures maximum retention of antibody specificity and sensitivity throughout the research timeline.

How can researchers validate the specificity of Phospho-ABL1 (Y204) Antibody?

Rigorous validation is essential for phospho-specific antibodies. Implement these methodological approaches:

• Phosphopeptide competition assay: Pre-incubate antibody with the phosphopeptide immunogen before application in Western blot. Signal disappearance confirms specificity .

• Phosphatase treatment: Treat one sample set with lambda phosphatase before Western blotting. Loss of signal confirms phospho-specificity.

• Kinase activation/inhibition: Compare samples treated with kinase activators (e.g., Adriamycin 0.5μg/ml for 24h as demonstrated in validation studies) versus controls .

• Genetic validation: Use CRISPR/Cas9 to generate Y204F mutants or ABL1 knockout cells as negative controls.

• Phospho-ELISA: Compare antibody binding to phospho-peptide versus non-phospho-peptide variants of the same sequence to confirm phospho-specificity .

These validation steps should be documented and included in publications to establish experimental rigor.

What critical controls should be incorporated when using Phospho-ABL1 (Y204) Antibody?

Implement these controls to ensure experimental validity:

These controls enable confident interpretation of experimental data and troubleshooting of inconsistent results.

How can researchers optimize signal-to-noise ratio when using Phospho-ABL1 (Y204) Antibody in Western blot?

To achieve optimal Western blot results with minimal background:

• Lysate preparation: Use phosphatase inhibitors (sodium orthovanadate, sodium fluoride, β-glycerophosphate) in lysis buffer to preserve phosphorylation.

• Blocking optimization: Test different blocking agents (5% BSA is often superior to milk for phospho-epitopes as milk contains phosphoproteins).

• Antibody dilution: Conduct a dilution series (1:500-1:2000) to determine optimal concentration .

• Incubation conditions: Extend primary antibody incubation to overnight at 4°C to enhance specific binding.

• Washing stringency: Increase number and duration of TBST washes to reduce non-specific signals.

• Detection system: Use high-sensitivity ECL reagents for weakly phosphorylated targets.

• Membrane selection: PVDF membranes often provide better results than nitrocellulose for phospho-epitopes, as demonstrated in validation studies with COS7 cells .

These optimizations should be systematically tested and documented for reproducible results.

What sample preparation methods optimize detection of phosphorylated ABL1 at Y204?

Phosphorylation states are highly labile and require specialized sample handling:

• Cell harvesting: Rapid processing is crucial—wash cells with ice-cold PBS containing phosphatase inhibitors.

• Lysis buffer composition:

  • Strong phosphatase inhibitor cocktail (10mM sodium pyrophosphate, 50mM NaF, 1mM Na₃VO₄)

  • Protease inhibitors (PMSF, aprotinin, leupeptin)

  • Non-denaturing detergent (1% NP-40 or Triton X-100)

  • Buffering agent (50mM Tris-HCl, pH 7.5)

• Lysis conditions: Maintain samples at 4°C throughout processing to minimize phosphatase activity.

• Sample storage: Add 6X Laemmli buffer immediately after quantification and heat at 95°C for 5 minutes; if storage is necessary, snap-freeze in liquid nitrogen.

• Loading amount: Use 20-50μg total protein per lane for most cell types; adjust based on expression level.

These methodological details preserve phosphorylation status and enable reliable detection of the Y204 phosphorylation site.

What signaling pathways involve ABL1 phosphorylation at Y204, and how can these be experimentally manipulated?

ABL1 Y204 phosphorylation participates in multiple signaling networks:

• DNA damage response: Adriamycin (0.5μg/ml) treatment for 24 hours activates Y204 phosphorylation .

• Growth factor signaling: PDGF-BB stimulation activates ABL1 through phosphorylation cascades similar to those observed with ERK pathway activation .

• Oxidative stress response: H₂O₂ treatment (0.5-1mM) can induce ABL1 activation.

• Cell adhesion pathways: Integrin engagement leads to ABL1 activation in certain cell types.

For experimental manipulation:

• Activators: Adriamycin, PDGF, EGF, oxidative stress inducers

• Inhibitors: Imatinib, Nilotinib, Dasatinib (varying specificity for ABL1)

• Genetic approaches: Expression of constitutively active ABL1 or dominant negative constructs

Investigation of these pathways should include time-course experiments to capture the transient nature of phosphorylation events.

How does ABL1 phosphorylation at Y204 compare with other ABL1 phosphorylation sites in functional significance?

ABL1 contains multiple phosphorylation sites with distinct regulatory functions:

When investigating ABL1 activation, consider analyzing multiple phosphorylation sites simultaneously to obtain a comprehensive understanding of activation status. Experiment design should account for the hierarchical and potentially cooperative nature of these phosphorylation events.

Why might researchers observe variable results with Phospho-ABL1 (Y204) Antibody across different cell lines?

Variability in experimental outcomes can stem from multiple factors:

• Basal phosphorylation levels: Cell lines differ in constitutive ABL1 activation; some may require stimulation to detect phospho-Y204.

• Phosphatase activity: Variable expression of protein tyrosine phosphatases (PTPs) affects steady-state phosphorylation.

• Expression level variation: Total ABL1 expression varies across cell types, affecting detection threshold.

• Stimulation sensitivity: Cell lines respond differently to activators; titrate stimulus concentration and timing.

• Sample preparation differences: Phosphorylation can be lost during processing if conditions aren't optimized for each cell type.

To address variability:

• Validate antibody in each new cell line

• Include positive controls (e.g., COS7 cells treated with Adriamycin)

• Optimize lysis conditions for each cell type

• Consider immunoprecipitation to enrich ABL1 before Western blotting in low-expressing lines

How can researchers quantify phosphorylated ABL1 levels relative to total ABL1 protein?

Accurate quantification requires normalization approaches:

• Dual immunoblotting method:

  • Strip and reprobe membrane with total ABL1 antibody

  • Calculate phospho-ABL1/total ABL1 ratio using densitometry

  • Avoid stripping if possible as it can reduce signal intensity

• Parallel blotting approach:

  • Run duplicate gels with identical samples

  • Probe one for phospho-ABL1 and the other for total ABL1

  • Normalize using housekeeping proteins on both blots

• Quantitative analysis:

  • Use digital imaging systems rather than film for wider linear range

  • Include a standard curve with known concentrations if absolute quantification is needed

  • Apply software that corrects for background and provides integrated density values

• Statistical analysis:

  • Perform at least three biological replicates

  • Apply appropriate statistical tests (t-test, ANOVA) to determine significance

  • Report both mean values and measures of variance

These approaches ensure that observed changes in phosphorylation represent actual biological events rather than variations in protein loading or expression.

What are the technical differences between using Phospho-ABL1 (Y204) Antibody in Western blot versus immunohistochemistry?

Different applications require specific methodological considerations:

For IHC specifically:

• Paraffin-embedded tissues require proper fixation (10% neutral buffered formalin) and antigen retrieval

• Phospho-epitopes are particularly sensitive to fixation time and conditions

• Breast carcinoma tissue has been validated as a positive control

• For negative controls, pre-absorb antibody with immunogen peptide

How can Phospho-ABL1 (Y204) Antibody contribute to cancer research?

Phospho-ABL1 (Y204) Antibody enables investigation of ABL1 activation in cancer contexts:

• Therapeutic response monitoring: Track ABL1 phosphorylation status before and after tyrosine kinase inhibitor treatment.

• Resistance mechanism studies: Analyze ABL1 activation in drug-resistant cancer cell populations.

• Biomarker development: Assess correlation between Y204 phosphorylation and clinical outcomes in tumor samples.

• Combination therapy rationale: Identify signaling nodes that remain active despite ABL1 inhibition.

• Cancer progression models: Map changes in Y204 phosphorylation across stages of carcinogenesis.

Recent studies have demonstrated applications in head and neck squamous cell carcinoma, showing that tumor-associated macrophages induce epithelial-to-mesenchymal transition via signaling pathways involving ERK1/2 phosphorylation, which follows similar activation mechanisms to ABL1 .

What emerging technologies might enhance the utility of Phospho-ABL1 (Y204) detection?

New methodological approaches expanding phospho-protein research include:

• Multiplexed detection: Simultaneous analysis of multiple phosphorylation sites using multiplexed Western blotting or mass spectrometry.

• Single-cell phospho-profiling: Techniques like CyTOF (mass cytometry) allow measurement of phospho-epitopes at single-cell resolution.

• Proximity ligation assay (PLA): Enables in situ detection of protein-protein interactions dependent on phosphorylation status.

• Phospho-proteomic integration: Combining antibody-based detection with mass spectrometry-based phospho-proteomics for comprehensive signaling analysis.

• CRISPR-based phosphorylation reporters: Engineered cellular systems that provide real-time monitoring of phosphorylation events.

• Simple Western™ technology: Automated capillary-based immunoassays provide higher reproducibility and quantitative analysis of phospho-proteins, similar to approaches validated with other phospho-specific antibodies .

Researchers should consider these emerging technologies when designing experiments for comprehensive phosphorylation analysis.